Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CGEN
COMPUGEN LTD.
NASDAQ
$2.60
▼ DOWN 5.80% (-0.16)

KEY STATISTICS

Market Cap$245.84 M
52w High$3.24
52w Low$1.30
Dividend Yield—
Frequency—
P/E6.84
Volume228.79K
Shares Out.94.55M

COMPANY

LEADERSHIP

Eran Ophir
CHIEF EXECUTIVE
Eran Ophir

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 11, 2000
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
75

PRICE TARGET

Target High$5.00
Target Low$5.00
Target Median$5.00
Target Consensus$5.00

UPCOMING EARNINGS

DateNov 9, 2026
DayMonday
Rev. Est.$1.28M
NOV
9
MON

PRICE

$2.60 ▼ DOWN 5.80% (−$0.16)
$2.60$2.65$2.70$2.759:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.60

About Compugen Ltd.

https://cgen.com ↗

Compugen Ltd. is a clinical-stage biotech in Israel, US, and Europe developing immuno-oncology therapeutics like anti-PVRIG and TIGIT antibodies, with collaborations including Bayer, Bristol-Myers Squibb, AstraZeneca, and Johns Hopkins.

INDUSTRY

Biotechnology

A PRODUCT COMPUGEN LTD. IS KNOWN FOR

Rilvegostomig
Rilvegostomig

Rilvegostomig, developed by AstraZeneca, is a bispecific antibody targeting PD-1 and TIGIT (from Compugen's COM902), in Phase 3 trials for various cancers, representing a key product from Compugen's platform.

COMPETITORS

COMPETITOR
GILD COMPARE
RCUS COMPARE

Revenue by Geography

MapREGIONFY2022FY2023FY2024FY2025
Unites States— $23.46M $22.86M ▼—
UNITED STATES— — — $7.76M
Europe$7.5M $10M ▲$5M ▼—

ETFS HOLDING THIS STOCK

ETFS HOLDING
8
LISTED HERE
5
RANKED BY POSITION SIZE
IZRL
1.80% · 887.9K
SPDW
0.00% · 351.0K
QQQS
0.51% · 42.5K
AI
AIIQ
0.97% · 14.4K
AESG
0.30% · 2.2K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
14.07%
HOLDERS
111
TOP 12 OF 111 · RANKED BY POSITION SIZE
Silverarc Capital Management, LLC
3.5M sh · $5.32M
Renaissance Technologies LLC
1.6M sh · $3.48M
Morgan Stanley
1.1M sh · $1.56M
Ark Investment Management LLC
1.0M sh · $2.24M
Macquarie Group Ltd
1.0M sh · $1.5M
Macquarie Management Holdings, Inc.
1.0M sh · $2.17M
Taylor Frigon Capital Management LLC
964.7K sh · $1.42M
Antonetti Capital Management LLC
766.5K sh · $712.87K
Blackrock Fund Advisors
713.4K sh · $3.64M
Northern Trust Corp
658.9K sh · $1.01M
Two Sigma Investments, LP
521.6K sh · $1.11M
State Street Corp
415.4K sh · $884.73K

RATINGS SNAPSHOT

Overall rating: A-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets5
Debt To Equity4
Price To Earnings3
Price To Book3
Overall Score4

INSIDER TRADES

★
DIRECTOR
Hukkelhoven Mathias
Purchase · 10.0K shares
2026-07-29
★
DIRECTOR
Halevy Gilead
Purchase · 10.0K shares
2026-07-29
★
OFFICER: SVP, BUSINESS DEVELOPMENT
Levine Zurit
Purchase · 24.0K shares
2026-07-29
★
OFFICER: CHIEF FINANCIAL OFFICER
Silberman David
Purchase · 19.5K shares
2026-07-29

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OUTPERFORM 1
1 GRADES IN THE LAST 12 MONTHS
Leerink Partners OUTPERFORM

SECTORS PEERS

PEERPRICE
NVCT$23.73COMPARE
TNXP$13.59COMPARE
IPHA$2.22COMPARE
CRBP$10.91COMPARE
MOLN$4.50COMPARE
MIST$1.16COMPARE
CRDF$0.94COMPARE
RANI$0.84COMPARE